Seaport Therapeutics, Inc. Common Stock (SPTX) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · United States · ISIN US81221K1088
Seaport Therapeutics, Inc. Common Stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Operating income | -52.42 m USD | -87.29 m USD |
| EBIT | -52.42 m USD | -87.29 m USD |
| Net income | -46.88 m USD | -74.88 m USD |
| Diluted EPS – continuing operations | -0.88 USD | -1.94 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Seaport Therapeutics, Inc. Common Stock
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety. The company's lead product candidate, GlyphAllo (SPT-300 or Glyph Allopregnanolone), is a novel, Glyphed oral prodrug of allopregnanolone, an endogenous molecule that has been clinically validated in third-party trials for the treatment of postpartum depression. Its second product candidate, GlyphAgo (SPT-320 or Glyph Agomelatine), is a novel, Glyphed oral prodrug of agomelatine, a clinically validated anxiolytic and antidepressant that is approved for the treatment of generalized anxiety disorder in Australia and major depressive disorder in Australia and the European Union. The company was founded in 2024 and is based in Boston, Massachusetts.
More stocks
- Securitize Corp. (SECZ)
- Vossloh (VOS.DE)
- Longwell Co (6290.TWO)
- Zhejiang Songyuan Automotive Safety (300893.SZ)
- Lumexa Imaging Holdings, Inc. Common Stock (LMRI)
- SOUTHSIDE BANCSHARES INC (SBSI)
- Huangshan Novel Co Ltd (002014.SZ)
- Supply Network Ltd (SNL.AX)
- Avalyn Pharma Inc. Common Stock (AVLN)
- Karat Packaging Inc. (KRT)
- Guangzhou Goaland Energy Conservation Tech Co Ltd (300499.SZ)
- EPIC Suisse AG (EPIC.SW)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.